About

We have a vision to become the world’s leading radiopharmaceutical
company, transforming the lives of people living with cancer

At RayzeBio, we get it done. Every patient deserves access to the best possible treatment, and we’re committed to making a difference in the lives of people with cancer. Radiopharmaceutical therapy is positioned to revolutionize the treatment of cancer – RayzeBio, a Bristol Myers Squibb Company – is committed to advancing radiopharmaceutical therapies through the clinic and to more patients to change lives. 

With a history rooted in biotech, now part of the best-in-class capabilities of Bristol Myers Squibb, we are harnessing the power of targeted radioisotopes to focus on improving survival of people living with cancer.

about-image-v2

Mission and Culture

We are a biotech with the backing and support of Bristol Myers Squibb, a leader in oncology, aiming to become the world’s leader in radiopharmaceutical therapeutics.

When we commit to things we focus on the controllables, and we get it done. Our say-to-do ratio is very high.

We help others around us become better. This is as important as improving ourselves as individuals. This is a team sport, and the diversity and engagement of our teams is a strength

We are unambiguous and transparent in our communication; we set clear goals and prioritize both speed and the quality of our decisions. Patients are waiting and we can’t waste time.

We are bold, agile and science-driven, focusing our energy on the most important priorities which have the potential to improve patient lives.

We do the right thing consistently including keeping our employees and patients safe.